IFP Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-14
| Closed | -$729 | – | 3543 |
|
|
2023
Q1 | $729 | Sell |
14
-405
| -97% | -$21.1K | ﹤0.01% | 3134 |
|
|
2022
Q4 | $22K | Sell |
419
-3
| -0.7% | -$158 | ﹤0.01% | 2815 |
|
|
2022
Q3 | $22K | Buy |
422
+17
| +4% | +$886 | ﹤0.01% | 3009 |
|
|
2022
Q2 | $21K | Hold |
405
| – | – | ﹤0.01% | 2803 |
|
|
2022
Q1 | $21K | Buy |
+405
| New | +$21K | ﹤0.01% | 2803 |
|
|
2019
Q4 | – | Sell |
-405
| Closed | -$20K | – | 3385 |
|
|
2019
Q3 | $20K | Buy |
+405
| New | +$20K | ﹤0.01% | 1761 |
|
|
2019
Q1 | $90K | Sell |
1,603
-431
| -21% | -$24.2K | 0.01% | 729 |
|
|
2018
Q4 | $94K | Sell |
2,034
-225
| -10% | -$10.4K | 0.01% | 1224 |
|
|
2018
Q3 | $134K | Hold |
2,259
| – | – | 0.01% | 1300 |
|
|
2018
Q2 | $124K | Sell |
2,259
-597
| -21% | -$32.8K | 0.01% | 1351 |
|
|
2018
Q1 | $135K | Hold |
2,856
| – | – | 0.01% | 1203 |
|
|
2017
Q4 | $135K | Buy |
2,856
+155
| +6% | +$7.33K | 0.01% | 1200 |
|
|
2017
Q3 | $135K | Buy |
2,701
+627
| +30% | +$31.3K | 0.01% | 1369 |
|
|
2017
Q2 | $95K | Buy |
2,074
+205
| +11% | +$9.39K | ﹤0.01% | 1543 |
|
|
2017
Q1 | $79K | Buy |
1,869
+101
| +6% | +$4.27K | ﹤0.01% | 1649 |
|
|
2016
Q4 | $69K | Sell |
1,768
-48
| -3% | -$1.87K | ﹤0.01% | 1677 |
|
|
2016
Q3 | $76K | Buy |
1,816
+201
| +12% | +$8.41K | ﹤0.01% | 1537 |
|
|
2016
Q2 | $60K | Buy |
1,615
+12
| +0.7% | +$446 | ﹤0.01% | 1654 |
|
|
2016
Q1 | $90K | Sell |
1,603
-967
| -38% | -$54.3K | 0.01% | 729 |
|
|
2015
Q4 | $130K | Buy |
+2,570
| New | +$130K | 0.01% | 1026 |
|